Novel approaches to epilepsy treatment

Epilepsia

Volumn 54, Issue 1, 2013, Pages 1-10

  Sørensen, Andreas T ^a,b   Kokaia, Merab ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cell transplantation; Gene therapy; Inhibitory neurotransmitters; Neuropeptides; Neurotrophic factors; Optogenetics

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE KINASE; ANTICONVULSIVE AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DOXYCYCLINE; FIBRONECTIN; GALANIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; KAINIC ACID; MESSENGER RNA; NEURON SPECIFIC ENOLASE; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; RHODOPSIN; VIRUS VECTOR; VOLTAGE GATED CALCIUM CHANNEL;

ADENO ASSOCIATED VIRUS; BRAIN DEPTH STIMULATION; BRAIN REGION; CELL SURVIVAL; CYTOMEGALOVIRUS; DISEASE EXACERBATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HIPPOCAMPUS; HUMAN; LIGHT EMITTING DIODE; MEMORY DISORDER; MESENCHYMAL STEM CELL; MOLECULAR GENETICS; NEURAL STEM CELL; NONHUMAN; OPTOGENETICS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; PYRIFORM CORTEX; REVIEW; SEIZURE; SIMIAN VIRUS; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

ANIMALS; EPILEPSIES, PARTIAL; EPILEPSY; GALANIN; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; NERVE GROWTH FACTORS; NEUROPEPTIDE Y; STEM CELL TRANSPLANTATION;

EID: 84872067224     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12000     Document Type: Review

References (80)

1. Baraban SC, Southwell DG, Estrada RC, Jones DL, Sebe JY, Alfaro-Cervello C, Garcia-Verdugo JM, Rubenstein JL, Alvarez-Buylla A,. (2009) Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc Natl Acad Sci USA 106: 15472-15477.
2. Bovolenta R, Zucchini S, Paradiso B, Rodi D, Merigo F, Navarro Mora G, Osculati F, Berto E, Marconi P, Marzola A, Fabene PF, Simonato M,. (2010) Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. J Neuroinflammation 7: 81.
3. Bowers WJ, Breakefield XO, Sena-Esteves M,. (2011) Genetic therapy for the nervous system. Hum Mol Genet 20: R28-R41.
4. Chow BY, Han X, Dobry AS, Qian X, Chuong AS, Li M, Henninger MA, Belfort GM, Lin Y, Monahan PE, Boyden ES,. (2010) High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 463: 98-102.
5. de Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, Duncan JS,. (2011) The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 378: 1388-1395.
6. Deisseroth K,. (2011) Optogenetics. Nat Methods 8: 26-29.
7. Duncan JS, Sander JW, Sisodiya SM, Walker MC,. (2006) Adult epilepsy. Lancet 367: 1087-1100.
8. During MJ, Spencer DD,. (1992) Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 32: 618-624.
9. El Bahh B, Balosso S, Hamilton T, Herzog H, Beck-Sickinger AG, Sperk G, Gehlert DR, Vezzani A, Colmers WF,. (2005) The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. Eur J Neurosci 22: 1417-1430.
10. Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, Gumnit R, Zahn C, Westbrook E, Enos B,. (2003) Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Epilepsia 44: 741-751.
11. Erickson JC, Clegg KE, Palmiter RD,. (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381: 415-421.
12. Fedele DE, Gouder N, Guttinger M, Gabernet L, Scheurer L, Rulicke T, Crestani F, Boison D,. (2005) Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain 128: 2383-2395.
13. Fink DJ, Wechuck J, Mata M, Glorioso JC, Goss J, Krisky D, Wolfe D,. (2011) Gene therapy for pain: results of a phase I clinical trial. Ann Neurol 70: 207-212.
14. Foti S, Haberman RP, Samulski RJ, McCown TJ,. (2007) Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo. Gene Ther 14: 1534-1536.
15. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK,. (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27: 59-65.
16. Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G,. (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21: 5804-5812.
17. Gnatkovsky V, Librizzi L, Trombin F, de Curtis M,. (2008) Fast activity at seizure onset is mediated by inhibitory circuits in the entorhinal cortex in vitro. Ann Neurol 64: 674-686.
18. Gotzsche CR, Nikitidou L, Sorensen AT, Olesen MV, Sorensen G, Christiansen SH, Angehagen M, Woldbye DP, Kokaia M,. (2012) Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures. Neurobiol Dis 45: 288-296.
19. Gouder N, Fritschy JM, Boison D,. (2003) Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44: 877-885.
20. Gradinaru V, Zhang F, Ramakrishnan C, Mattis J, Prakash R, Diester I, Goshen I, Thompson KR, Deisseroth K,. (2010) Molecular and cellular approaches for diversifying and extending optogenetics. Cell 141: 154-165.
21. Gray SJ, Blake BL, Criswell HE, Nicolson SC, Samulski RJ, McCown TJ, Li W,. (2010) Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB). Mol Ther 18: 570-578.
22. Gross RE, Watts RL, Hauser RA, Bakay RA, Reichmann H, von Kummer R, Ondo WG, Reissig E, Eisner W, Steiner-Schulze H, Siedentop H, Fichte K, Hong W, Cornfeldt M, Beebe K, Sandbrink R,. (2011) Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol 10: 509-519.
23. Haberman RP, Samulski RJ, McCown TJ,. (2003) Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med 9: 1076-1080.
24. Huang EJ, Reichardt LF,. (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736.
25. Huber A, Padrun V, Deglon N, Aebischer P, Mohler H, Boison D,. (2001) Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci USA 98: 7611-7616.
26. Jeon D, Chu K, Lee ST, Jung KH, Kang KM, Ban JJ, Kim S, Seo JS, Won CH, Kim M, Lee SK, Roh JK,. (2011) A cell-free extract from human adipose stem cells protects mice against epilepsy. Epilepsia 52: 1617-1626.
27. Kanter-Schlifke I, Georgievska B, Kirik D, Kokaia M,. (2007a) Seizure suppression by GDNF gene therapy in animal models of epilepsy. Mol Ther 15: 1106-1113.
28. Kanter-Schlifke I, Toft Sorensen A, Ledri M, Kuteeva E, Hokfelt T, Kokaia M,. (2007b) Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity. Neuroscience 150: 984-992.
29. Kaplitt MG, During MJ,. (2006) Gene therapy in the central nervous system. From bench to bedside. Elsevier Inc., San Diego, CA.
30. Leung CH, Kliem MA, Heeke BL, McPhee SW, Federici T, Snyder BR, Boulis NM,. (2011) Assessment of hippocampal adeno-associated viral vector gene delivery via frameless stereotaxis in a nonhuman primate. Stereotact Funct Neurosurg 89: 275-285.
31. LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A,. (2011) AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10: 309-319.
32. Li S, Xu B, Martin D, Racine RJ, Fahnestock M,. (2002) Glial cell line-derived neurotrophic factor modulates kindling and activation-induced sprouting in hippocampus of adult rats. Exp Neurol 178: 49-58.
33. Li T, Steinbeck JA, Lusardi T, Koch P, Lan JQ, Wilz A, Segschneider M, Simon RP, Brustle O, Boison D,. (2007) Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 130: 1276-1288.
34. Li T, Ren G, Kaplan DL, Boison D,. (2009) Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis. Epilepsy Res 84: 238-241.
35. Lin EJ, Richichi C, Young D, Baer K, Vezzani A, During MJ,. (2003) Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci 18: 2087-2092.
36. Lin EJ, Young D, Baer K, Herzog H, During MJ,. (2006) Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice. Epilepsia 47: 773-780.
37. Lindvall O, Barker RA, Brustle O, Isacson O, Svendsen CN,. (2012) Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell 10: 151-155.
38. Loscher W, Schmidt D,. (2011) Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 52: 657-678.
39. Louboutin JP, Chekmasova AA, Marusich E, Chowdhury JR, Strayer DS,. (2010) Efficient CNS gene delivery by intravenous injection. Nat Methods 7: 905-907.
40. Luoni C, Bisulli F, Canevini MP, De Sarro G, Fattore C, Galimberti CA, Gatti G, La Neve A, Muscas G, Specchio LM, Striano S, Perucca E,. (2011) Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia 52: 2181-2191.
41. Maisano X, Litvina E, Tagliatela S, Aaron GB, Grabel LB, Naegele JR,. (2012) Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy. J Neurosci 32: 46-61.
42. Mantoan L, Wykes RC, Schorge S, Walker MC, Kullmann DM,. (2011) Optogenetic suppression of high-frequency EEG activity in a model of focal epilepsy. Society for Neuroscience Meeting, November 12-16, 2011, Washington, D.C., abstract, 67221/Y20.
43. Martin D, Miller G, Rosendahl M, Russell DA,. (1995) Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat. Brain Res 683: 172-178.
44. Mazarati AM,. (2004) Galanin and galanin receptors in epilepsy. Neuropeptides 38: 331-343.
45. Mazarati A, Wasterlain CG,. (2002) Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus. Neurosci Lett 331: 123-127.
46. Mazarati AM, Liu H, Soomets U, Sankar R, Shin D, Katsumori H, Langel U, Wasterlain CG,. (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 18: 10070-10077.
47. McCown TJ,. (2006) Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther 14: 63-68.
48. McCown TJ,. (2011) Adeno-associated virus (AAV) vectors in the CNS. Curr Gene Ther 11: 181-188.
49. Noe F, Pool AH, Nissinen J, Gobbi M, Bland R, Rizzi M, Balducci C, Ferraguti F, Sperk G, During MJ, Pitkanen A, Vezzani A,. (2008) Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 131: 1506-1515.
50. Noe F, Vaghi V, Balducci C, Fitzsimons H, Bland R, Zardoni D, Sperk G, Carli M, During MJ, Vezzani A,. (2010) Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus. Gene Ther 17: 643-652.
51. Olesen MV, Christiansen SH, Gotzsche CR, Nikitidou L, Kokaia M, Woldbye DP,. (2012) Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice. J Neurosci Res 90: 498-507.
52. Paradiso B, Marconi P, Zucchini S, Berto E, Binaschi A, Bozac A, Buzzi A, Mazzuferi M, Magri E, Navarro Mora G, Rodi D, Su T, Volpi I, Zanetti L, Marzola A, Manservigi R, Fabene PF, Simonato M,. (2009) Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci USA 106: 7191-7196.
53. Paradiso B, Zucchini S, Su T, Bovolenta R, Berto E, Marconi P, Marzola A, Navarro Mora G, Fabene PF, Simonato M,. (2011) Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus. Epilepsia 52: 572-578.
54. Reibel S, Larmet Y, Le BT, Carnahan J, Marescaux C, Depaulis A,. (2000) Brain-derived neurotrophic factor delays hippocampal kindling in the rat. Neuroscience 100: 777-788.
55. Ren G, Li T, Lan JQ, Wilz A, Simon RP, Boison D,. (2007) Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol 208: 26-37.
56. Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A,. (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 24: 3051-3059.
57. Ruschenschmidt C, Koch PG, Brustle O, Beck H,. (2005) Functional properties of ES cell-derived neurons engrafted into the hippocampus of adult normal and chronically epileptic rats. Epilepsia 46 (Suppl. 5): 174-183.
58. Sagher O, Thawani JP, Etame AB, Gomez-Hassan DM,. (2012) Seizure outcomes and mesial resection volumes following selective amygdalohippocampectomy and temporal lobectomy. Neurosurg Focus 32: E8.
59. Scharfman HE, Goodman JH, Sollas AL, Croll SD,. (2002) Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 174: 201-214.
60. Simonato M, Tongiorgi E, Kokaia M,. (2006) Angels and demons: neurotrophic factors and epilepsy. Trends Pharmacol Sci 27: 631-638.
61. Sperk G, Marksteiner J, Gruber B, Bellmann R, Mahata M, Ortler M,. (1992) Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience 50: 831-846.
62. Thammongkol S, Vears DF, Bicknell-Royle J, Nation J, Draffin K, Stewart KG, Scheffer IE, Mackay MT,. (2012) Efficacy of the ketogenic diet: which epilepsies respond? Epilepsia Feb 6 [Epub ahead of print]. Mar; 53 (3): e55-9. doi: 10.1111/j.1528-1167.2011.03394.x
63. Theofilas P, Brar S, Stewart KA, Shen HY, Sandau US, Poulsen D, Boison D,. (2011) Adenosine kinase as a target for therapeutic antisense strategies in epilepsy. Epilepsia 52: 589-601.
64. Thompson KW, Suchomelova LM,. (2004) Transplants of cells engineered to produce GABA suppress spontaneous seizures. Epilepsia 45: 4-12.
65. Thompson K, Anantharam V, Behrstock S, Bongarzone E, Campagnoni A, Tobin AJ,. (2000) Conditionally immortalized cell lines, engineered to produce and release GABA, modulate the development of behavioral seizures. Exp Neurol 161: 481-489.
66. Tønnesen J, Sørensen AT, Deisseroth K, Lundberg C, Kokaia M,. (2009) Optogenetic control of epileptiform activity. Proc Natl Acad Sci USA 106: 12162-12167.
67. Tye KM, Prakash R, Kim SY, Fenno LE, Grosenick L, Zarabi H, Thompson KR, Gradinaru V, Ramakrishnan C, Deisseroth K,. (2011) Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 471: 358-362.
68. Van Dycke A, Raedt R, Dauwe I, Sante T, Wyckhuys T, Meurs A, Vonck K, Wadman W, Boon P,. (2010) Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures. Epilepsia 51: 1721-1728.
69. Vezzani A, Sperk G, Colmers WF,. (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22: 25-30.
70. Vezzani A, Michalkiewicz M, Michalkiewicz T, Moneta D, Ravizza T, Richichi C, Aliprandi M, Mule F, Pirona L, Gobbi M, Schwarzer C, Sperk G,. (2002) Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110: 237-243.
71. Wang J, Wagner F, Borton DA, Zhang J, Ozden I, Burwell RD, Nurmikko AV, van Wagenen R, Diester I, Deisseroth K,. (2012) Integrated device for combined optical neuromodulation and electrical recording for chronic in vivo applications. J Neural Eng 9: 016001.
72. Weinberg MS, Blake BL, Samulski RJ, McCown TJ,. (2011) The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5. Gene Ther 18: 961-968.
73. Witten IB, Lin SC, Brodsky M, Prakash R, Diester I, Anikeeva P, Gradinaru V, Ramakrishnan C, Deisseroth K,. (2010) Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 330: 1677-1681.
74. Woldbye DP, Angehagen M, Gotzsche CR, Elbrond-Bek H, Sorensen AT, Christiansen SH, Olesen MV, Nikitidou L, Hansen TV, Kanter-Schlifke I, Kokaia M,. (2010) Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures. Brain 133: 2778-2788.
75. Xu B, Michalski B, Racine RJ, Fahnestock M,. (2002) Continuous infusion of neurotrophin-3 triggers sprouting, decreases the levels of TrkA and TrkC, and inhibits epileptogenesis and activity-dependent axonal growth in adult rats. Neuroscience 115: 1295-1308.
76. Yizhar O, Fenno LE, Davidson TJ, Mogri M, Deisseroth K,. (2011) Optogenetics in neural systems. Neuron 71: 9-34.
77. Yoo YM, Lee CJ, Lee U, Kim YJ,. (2006) Neuroprotection of adenoviral-vector-mediated GDNF expression against kainic-acid-induced excitotoxicity in the rat hippocampus. Exp Neurol 200: 407-417.
78. Zhang F, Gradinaru V, Adamantidis AR, Durand R, Airan RD, de Lecea L, Deisseroth K,. (2010) Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat Protoc 5: 439-456.
79. Zhao S, Ting JT, Atallah HE, Qiu L, Tan J, Gloss B, Augustine GJ, Deisseroth K, Luo M, Graybiel AM, Feng G,. (2011) Cell type-specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nat Methods 8: 745-752.
80. Zipancic I, Calcagnotto ME, Piquer-Gil M, Mello LE, Alvarez-Dolado M,. (2010) Transplant of GABAergic precursors restores hippocampal inhibitory function in a mouse model of seizure susceptibility. Cell Transplant 19: 549-564.